BRCA1 in cancer, cell cycle and genomic stability

Frontiers in Bioscience

Volumn 8, Issue SUPPL., 2003, Pages

  Jhanwar Uniyal, Meena ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

BRCA1; Breast; Cancer; Cell cycle; DNA; Methylation; Mutations; Repair; Review

Indexed keywords

ATM PROTEIN; BRCA1 PROTEIN; BRCA2 PROTEIN; CASEIN KINASE II; CYCLIN DEPENDENT KINASE; CYCLINE; HISTONE DEACETYLASE; MISMATCH REPAIR PROTEIN; PROTEIN; PROTEIN P53; RETINOBLASTOMA PROTEIN; RNA POLYMERASE II; STAT PROTEIN; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG;

BREAST CANCER; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL CYCLE; DISEASE ASSOCIATION; DNA REPAIR; EPIGENETICS; EXON; FRAMESHIFT MUTATION; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE INACTIVATION; GENE INSERTION; GENE ISOLATION; GENE MUTATION; GENETIC STABILITY; HETEROZYGOSITY LOSS; HIGH RISK POPULATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; METHYLATION; MOLECULAR RECOGNITION; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; ONCOGENE; ONCOGENE C MYC; OVARY CANCER; PHENOTYPE; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; TRANSCRIPTION INITIATION; TUMOR CELL; TUMOR SUPPRESSOR GENE; ANIMAL; GENE SILENCING; GENETICS; NEOPLASM; PATHOLOGY; PHYSIOLOGY;

INSERTION SEQUENCES;

ANIMALS; CELL CYCLE; GENE SILENCING; GENES, BRCA1; HUMANS; LOSS OF HETEROZYGOSITY; NEOPLASMS;

EID: 3142670793     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: None     Document Type: Review

References (93)

1. Li,C.I., B.O Anderson, ,J.R., Dalingand & R.E. Moe: Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 289, 1421-1424 (2003a)
2. Li,C.I., J.R. Daling & K.E. Malone: Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998. J. Clin. Oncol. 21, 28-34 (2003b).
3. Li,C.I., K.E. Malone & J.R. Daling: Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch. Intern. Med. 163, 49-56 (2003c)
4. Szabo,C.I. & M.C. King: Inherited breast and ovarian cancer. Hum. Mol. Genet. 4 Spec No, 1811-1817(1995)
5. Welcsh,P.L., M.K. Lee, R.M. Gonzalez-Hernandez,D.J. Black,M. Mahadevappa,E.M.Swisher,J.A. Warrington & M.C. King: BRCA1 transcriptionally regulates genes involved in breast tumorigenesis. Proc. Natl. Acad. Sci. U. S. A 99, 7560-7565(2002)
6. Futreal,P.A.,Q.Liu,D.Shattuck-Eidens, C. Cochran, K. Harshman,S. Tavtigian, L.M .Bennett, A. Haugen-Strano, J.Swensen, &Y., Miki, et al., BRCA1 mutations in primary breast and ovarian carcinomas. Science 266, 120-122 (1994)
7. Welcsh,P.L. & M.C. King: BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. 22. Hum. Mol. Genet. 10, 705-713(2001)
8. Miki,Y.,J.Swensen, D.Shattuck-Eidens, P.A. Futreal,K. Harshman,S.Tavtigian,Q.Liu,C.Cochran,L.M.Bennett, W. Ding, et al: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66-71(1994)
9. Ramus,S.J., P.D.Pharoah,P. Harrington,C. Pye,B. Werness,L. Bobrow,A. Ayhan, D. Wells, A. Fishman,M.Gore, R.A.DiCioccio,M.S. Piver, A.S.Whittemore,B.A. Ponder & S.A.,Gayther: BRCA1/2 mutation status influences somatic genetic progression in inherited and sporadic epithelial ovarian cancer cases. Cancer Res. 63, 417-423(2003)
10. Merajver,S.D., T.S.Frank,J. Xu, T.M.Pham, K.A.Calzone,P.Bennett-Baker, J.Chamberlain,J. Boyd,J.E. Garber,F.S., Collins, et al.,: Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer. Clin. Cancer Res. 1, 539-544(1995)
11. Johannsson,O.T., I.Idvall,C. Anderson,A. Borg,R.B. Barkardottir,V. Egilsson & H.,Olsson: Tumour biological features of BRCA1-induced breast and ovarian cancer. Eur. J. Cancer 33, 362-371(1997)
12. Gayther,S.A., P. Harrington, P. Russell,G. Kharkevich, R.F. Garkavtseva, & B.A.,Ponder: Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia. Am. J. Hum. Genet. 60, 1239-1242(1997)
13. Sobol,H., D.Stoppa-Lyonnet,B.Bressac-de-Paillerets, J.P.Peyrat, F.Kerangueven, N.Janin, T.Noguchi, F. Eisinger,J.M. Guinebretiere,J. Jacquemier,&,D., Birnbaum: Truncation at conserved terminal regions of BRCA1 protein is associated with highly proliferating hereditary breast cancers. Cancer Res. 56, 3216-3219(1996).
14. Rodenhiser,D.I., J.D.Andrews,D.N.Mancini,J.H.Jung,& S.M., Singh: Homonucleotide tracts, short repeats and CpG/CpNpG motifs are frequent sites for heterogeneous mutations in the neurofibromatosis type 1 (NF1) tumour-suppressor gene. Mutat. Res. 373, 185-195(1997)
15. Struewing,J.P., D. Abeliovich,T. Peretz,N. Avishai,M.M.Kaback,F.S. Collins & L.C.,Brody: The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat. Genet. 11, 198-200 (1995)
16. Offit,K., T. Gilewski,P. McGuire,A.Schluger,H. Hampel,K. Brown,J.Swensen,S. Neuhausen,M.Skolnick,L. Norton & D. Goldgar Germline BRCA1 185delAG mutations in Jewish women with breast cancer. Lancet 347, 1643-1645(1996)
17. Bahar,A.Y.,P.J. Taylor,L. Andrews,A. Proos,L. Burnett,K.Tucker,M. Friedlander & M.F.Buckley: The frequency of founder mutations in the BRCA1, BRCA2, and APC genes in Australian Ashkenazi Jews: implications for the generality of U.S. population data. Cancer 92, 440-445. (2001)
18. Neuhausen,S.L., S.Mazoyer,L.Friedman,M.Stratton,K. Offit,A.Caligo,G. Tomlinson,L.Cannon-Albright, T.Bishop, D.Kelsell,E.Solomon,B.Weber,F. Couch,J. Struewing, P.Tonin,F. Durocher, S.Narod, M.H.Skolnick, G.Lenoir, O.Serova, B.Ponder,D.Stoppa-Lyonnet, D. Easton, M.C.King & D.E. Goldgar: Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am. J. Hum. Genet. 58, 271-280(1996)
19. Olopade,O.I., J.D. Fackenthal,G.Dunston,M.A.Tainsky, F. Collins& D.E. Whitfield-Broome: Breast cancer genetics in African Americans. Cancer 97, 236-245(2003)
20. Gazdar,A.F., V. Kurvari,A.Virmani,L. Gollahon, M.Sakaguchi,M. Westerfield, D. Kodagoda, V.Stasny, H.T. Cunningham,I.I. Wistuba, G. Tomlinson, V. Tonk, R.Ashfaq, A.M. Leitch, J.D.Minna & J.W. Shay: Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer. Int. J. Cancer 78, 766-774(1998)
21. Rohlfs,E.M., C.H.Chung,Q. Yang,C. Skrzynia,W.W. Grody,M.L. Graham & L.M. Silverman In-frame deletions of BRCA1 may define critical functional domains. Hum. Genet. 107, 385-390 (2000)
22. Ruffner,H., C.A.Joazeiro,D. Hemmati,T.Hunter & I.M. Verma:Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity. Proc. Natl. Acad. Sci. U. S. A 98, 5134-5139(2001)
23. Fan,S., R. Yuan,Y.X. Ma,Q. Meng,I.D.Goldberg & E.M. Rosen:Mutant BRCA1 genes antagonize phenotype of wild-type BRCA1. Oncogene 20, 8215-8235(2001)
24. Catteau,A., W.H. Harris,C.F.Xu & E. Solomon: Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene 18, 1957-1965(1999)
25. Jhanwar-Uniyal, M., G. D Stephenson, R. Royak-Schaler, C.-X Wang, M. Achary, A.P. Albino & J. Whysner: Involvement of p53 and BRCA1 genes in Breast Cancer in African-American and White Woman. Proc.American Association for Cancer Research 44, 1132-1133 (2003)
26. Archey, W.B., K.A. McEachern,M. Robson, K. Offit,K., S.A.Vaziri, G. Casey,A.Borg & B.A. Arrick: Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers. Oncogene 21, 7034-7041(2002)
27. Bird,A. DNA methylation de novo. Science 286, 2287-2288(1999)
28. Xu,C.F., M.A.Brown, J.A.Chambers,B. Griffiths,H. Nicolai & E. Solomon: Distinct transcription start sites generate two forms of BRCA1 mRNAHum. Mol. Genet. 4, 2259-2264(1995)
29. Xu,C.F., M.A.Brown,H. Nicolai,J.A. Chambers,B.L. Griffiths & E. Solomon: Isolation and characterisation of the NBR2 gene which lies head to head with the human BRCA1 gene. Hum. Mol. Genet. 6, 1057-1062(1997a)
30. Xu,C.F., J.A.Chambers & E. Solomon: Complex regulation of the BRCA1 gene. J. Biol. Chem. 272, 20994-20997(1997b)
31. Klein-Hitpass,L., M. Schorpp,U. Wagner & G.U., Ryffel:An estrogen-responsive element derived from the 5′ flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells. Cell 46, 1053-1061 (1986).
32. Brown,M.A., C.F.Xu,H. Nicolai,B. Griffiths,J.A. Chambers,D. Black & E. Solomon: The 5′ end of the BRCA1 gene lies within a duplicated region of human chromosome 17q21. Oncogene 12, 2507-2513(1996)
33. Thakur, S. & C.M.,Croce Positive regulation of the BRCA1 promoter. J. Biol. Chem. 274, 8837-8843 (1999)
34. Esteller,M., J.M. Silva,G. Dominguez,F. Bonilla,X. Matias-Guiu,E. Lerma, E. Bussaglia,J. Prat,I.C, Harkes,E.A. Repasky,E. Gabrielson,M. Schutte,S.B. Baylin & J.G. Herman: Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J. Natl. Cancer Inst. 92, 564-569(2000)
35. Bertucci,F., F. Eisinger,R. Tagett,H. Sobol & D.Birnbaum: Re: Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers. J. Natl. Cancer Inst. 94, 1506-1507(2002)
36. Miyamoto,K., T. Fukutomi,K. Asada,K. Wakazono,H. Tsuda,T. Asahara, T.Sugimura & T. Ushijima: Promoter hypermethylation and post-transcriptional mechanisms for reduced BRCA1 immunoreactivity in sporadic human breast cancers. Jpn. J. Clin. Oncol. 32, 79-84(2002)
37. Mancini,D.N., D.I.Rodenhiser,P.J. Ainsworth,F.P. O'Malley,S.M. Singh,W. Xing & T.K. Archer: CpG methylation within the 5′ regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site. Oncogene 16, 1161-1169(1998)
38. Magdinier,F., S.Ribieras,G.M. Lenoir,L. Frappart & R. Dante: Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region. Oncogene 17, 3169-3176(1998)
39. DiNardo,D.N., D.T.Butcher,D.P. Robinson,T.K. Archer & D.I.Rodenhiser: Functional analysis of CpG methylation in the BRCA1 promoter region. Oncogene 20, 5331-5340(2001)
40. MacLeod,M.C: A possible role in chemical carcinogenesis for epigenetic, heritable changes in gene expression. Mol. Carcinog. 15, 241-250(1996)
41. Catteau,A., C.F. Xu,M.A.Brown,S. Hodgson,J. Greenman,C.G. Mathew, A.M. Dunning & E. Solomon: Identification of a C/G polymorphism in the promoter region of the BRCA1 gene and its use as a marker for rapid detection of promoter deletions. Br. J. Cancer 79, 759-763(1999b)
42. Jhanwar-Uniyal, M., S.A.Hoda, A.Raziuddin, D.M. Knowles, H.-F.Kung,S.C. Gulati, & R. Raziuddin: BRCA1 promoter-specific DNA binding protein activity in estrogen dependent breast tumor tissue is mediated by NF-kB nuclear factor. Proc.American Association for Cancer Research 38, 562-563(1997)
43. Ferguson,A.T., R.G.Lapidus,S.B. Baylin & N.E.Davidson: Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression. Cancer Res. 55, 2279-2283(1995)
44. Sourvinos,G. & D.A. Spandidos: Decreased BRCA1 expression levels may arrest the cell cycle through activation of p53 checkpoint in human sporadic breast tumors. Biochem. Biophys. Res. Commun. 245, 75-80(1998)
45. Thompson,M.E., R.A. Jensen,P.S. Obermiller,D.L. Page & J.T.Holt: Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat. Genet. 9, 444-450(1995)
46. Hedenfalk,I., D. Duggan,Y. Chen,M. Radmacher,M. Bittner,R. Simon,P. Meltzer, B. Gusterson, M. Esteller, O.P. Kallioniemi,B. Wilfond,A. Borg & J. Trent: Gene-expression profiles in hereditary breast cancer. N. Engl. J. Med. 344, 539-548 (1995)
47. Yarden,R.I. & L.C.Brody: BRCA1 interacts with components of the histone deacetylase complex. Proc. Natl. Acad. Sci. U. S. A 96, 4983-4988(1999)
48. Fabbro,M. & B.R.Henderson: Regulation of tumor suppressors by nuclear-cytoplasmic shuttling. Exp. Cell Res. 282, 59-69(2003)
49. Koonin,E.V., S.F.Altschul & P. Bork: BRCA1 protein products ... Functional motifs.. Nat. Genet. 13, 266-268(1996)
50. Deng,C.X. & S.G. Brodie: Roles of BRCA1 and its interacting proteins. Bioessays 22, 728-737(2000)
51. Xian,M.Y., S. Fan,J. Xiong,R.Q. Yuan,Q. Meng,M. Gao,I.D. Goldberg,S.A. Fuqua,R.G. Pestell & E.M.Rosen: Role of BRCA1 in heat shock response. Oncogene 22, 10-27(2003)
52. Liu,Y., D.M.Virshup, R.L. White &L.C. Hsu: Regulation of BRCA1 phosphorylation by interaction with protein phosphatase 1alpha. Cancer Res. 62, 6357-6361(2002)
53. Aprelikova,O.N., B.S.Fang,E.G. Meissner,S. Cotter,M. Campbell,A. Kuthiala, M.Bessho,R.A. Jensen, & E.T. Liu: BRCA1-associated growth arrest is RB-dependent. Proc. Natl. Acad. Sci. U. S. A 96, 11866-11871(1999)
54. Callebaut,I. & J.P.Mornon: From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair. FEBS Lett. 400, 25-30(1997)
55. Stewart,G.S., B.Wang,C.R. Bignell,A.M. Taylor & S.J.Elledge: MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature 421, 961-966(2003)
56. Wu,L.J.C., Z.W. Wang,J.T. Tsan,M.A. Spillman,A. Phung,X.L. Xu,M.C.W. Yang, L.Y. Hwang,A.M. Bowcock & R. Baer: Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nature Genetics 14, 430-440(1996)
57. Jensen,D.E., M.Proctor,S.T. Marquis,H.P. Gardner,S.I. Ha,L.A. Chodosh, A.M. Ishov,N. Tommerup,H. Vissing,Y. Sekido,J. Minna,A. Borodovsky,D.C. Schultz, K.D.Wilkinson,G.G. Maul,N. Barlev,S.L. Berger,G.C. Prendergast & F.J. Rauscher III: BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene 16, 1097-1112(1998)
58. Jensen,D.E. & F.J. Rauscher, III:Defining biochemical functions for the BRCA1 tumor suppressor protein: analysis of the BRCA1 binding protein BAP1. Cancer Lett. 143 Suppl 1, 813-817(1999)
59. Chen,A., F.E.Kleiman,J.L. Manley,T. Ouchi & Z.Q. Pan: Autoubiquitination of the BRCA1*BARD1 RING ubiquitin ligase. J. Biol. Chem. 277, 22085-22092(2002)
60. Lorick,K.L., J.P.Jensen,S. Fang,A.M. Ong,S. Hatakeyama, & A.M. Weissman: RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc. Natl Acad. Sci. U. S. A 96, 11364-11369(1999)
61. Ruffner,H., W.Jiang,A.G. Craig,T. Hunter & I.M. Verma: BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site. Mol. Cell Biol. 19, 4843-4854(1999)
62. Moynahan,M.E.:The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans. Oncogene 21, 8994-9007(2002)
63. Arizti,P., L.Fang,I. Park,Y. Yin,E. Solomon,T. Ouchi,S.A. Aaronson & S.W. Lee: Tumor suppressor p53 is required to modulate BRCA1 expression. Mol. Cell Biol. 20, 7450-7459(2000)
64. MacLachlan,T.K., B.C.Dash,D.T. Dicker & W.S. El Deiry: Repression of BRCA1 through a feedback loop involving p53. J. Biol. Chem. 275, 31869-31875(2000)
65. MacLachlan,T.K., R.Takimoto & W.S. El Deiry: BRCA1 directs a selective p53-dependent transcriptional response towards growth arrest and DNA repair targets. Mol. Cell Biol. 22, 4280-4292(2002)
66. Kinzler,K.W. & B. Vogelstein: Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 386, 761, 763(1997)
67. Xia,Y., G.M. Pao,H.W. Chen,I.M. Verma & T. Hunter: Enhancement of BRCA1 E3 Ubiquitin Ligase Activity through Direct Interaction with the BARD1 Protein. J. Biol. Chem. 278, 5255-5263(2003)
68. Wang,Q., H. Zhang,K. Kajino & M.I. Greene: BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells. Oncogene 17, 1939-1948(1998)
69. Ouchi,T., S.W.Lee,M. Ouchi,S.A. Aaronson & C.M. Horvath: Collaboration of signal transducer and activator of transcription 1 (STAT1) and BRCA1 in differential regulation of IFN-gamma target genes. Proc. Natl. Acad. Sci. U. S. A 97, 5208-5213(2000)
70. Scully,R., J.J.Chen, R.L.Ochs,K. Keegan,M. Hoekstra,J. Feunteun & D.M. Livingston: Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 90, 425-435(1997)
71. Scully,R., J.Chen,A. Plug,Y. Xiao,D. Weaver,J. Feunteun,T. Ashley & D.M. Livingston: Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88, 265-275(1997)
72. Scully,R. & D.M. Livingston (2000) In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408, 429-432.
73. Chen,J., D.P. Silver,D. Walpita,S.B. Cantor,A.F. Gazdar,G. Tomlinson,F.J. Couch,B.L. Weber,T. Ashley,D.M. Livingston & R.Scully: Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. Mol. Cell 2, 317-328(1998)
74. Ivanov,E.L. & J.E. Haber: DNA repair: RAD alert. Curr. Biol. 7, R492-R495(1997)
75. Wang,Y., D. Cortez, P.Yazdi,N. Neff, S.J. Elledge & J. Qin: BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev. 14, 927-939(2000)
76. Zhong,Q., C.F.Chen,S. Li,Y. Chen,C.C. Wang,J. Xiao,P.L. Chen,Z.D. Sharp & W.H.Lee: Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. Science 285, 747-750(1999)
77. Venkitaraman,A.R.: Breast cancer genes and DNA repair. Science 286, 1100-1102(1999)
78. Venkitaraman,A.R.:Functions of BRCA1 and BRCA2 in the biological response to DNA damage. J. Cell Sci. 114, 3591-3598(2001)
79. Venkitaraman,A.R.: Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108, 171-182(2002)
80. Cortez,D., Y. Wang,J. Qin & S.J.Elledge: Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. Science 286, 1162-1166(1999)
81. Tibbetts,R.S., D. Cortez,K.M. Brumbaugh,R. Scully,D. Livingston,S.J. Elledge & R.T.Abraham: Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev. 14, 2989-3002(2000)
82. Elledge,S.J. & A. Amon: The BRCA1 suppressor hypothesis: an explanation for the tissue-specific tumor development in BRCA1 patients. Cancer Cell 1, 129-132(2002)
83. Paull,T.T., D.Cortez,B. Bowers,S.J. Elledge & M. Gellert: Direct DNA binding by Brca1. Proc. Nad. Acad. Sci. U. S. A 98, 6086-6091(2001)
84. Gowen,L.C., A.V. Avrutskaya,A.M. Latour,B.H. Koller & S.A.Leadon: BRCA1 required for transcription-coupled repair of oxidative DNA damage. Science 281, 1009-1012 (1998)
85. Bernstein,C.,H. Bernstein,C.M. Payne & H.Garewal: DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutat. Res. 511, 145-178(2002)
86. Thomspson L.H.& D.Schild: Recombinational DNA repair and human disease. Mutat. Res 509, 49-78(2002)
87. Khanna,K.K. & S.P.Jackson: DNA double-strand breaks: signaling, repair and the cancer connection. Nat. Genet. 27, 247-254(2001)
88. Cantor,S.B., D.W.Bell,S. Ganesan,E.M. Kass,R. Drapkin,S. Grossman,D.C. Wahrer,D.C. Sgroi,W.S. Lane,D.A. Haber & D.M.Livingston: BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell 105, 149-160(2001)
89. Gatei,M., K. Sloper,C. Sorensen,R. Syljuasen,J. Falck,K. Hobson,K. Savage, J. Lukas,B.B. Zhou,J. Bartek & K.K.Khanna: ATM and NBS1 dependent phosphorylation of CHK1 on S317 in response to IR. J Biol. Chem. (2003) In Press.
90. Yarden,R.I., S. Pardo-Reoyo,M. Sgagias,K.H. Cowan & L.C. Brody: BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nat. Genet. 30, 285-289(2002)
91. Oe,T., N. Nakajo,Y.Katsuragi, K. Okazaki & N. Sagata: Cytoplasmic occurrence of the Chk1/Cdc25 pathway and regulation of Chk1 in Xenopus oocytes. Dev. Biol. 229, 250-261(2001)
92. Okada,S. & T., Ouchi: Cell Cycle Differences in DNA Damage-induced BRCA1 Phosphorylation Affect Its Subcellular Localization. J. Biol. Chem. 278, 2015-2020 (2003)
93. Williams,R.S. & J.N.,Glover: Structural Consequences of a Cancer-causing BRCA1-BRCT Missense Mutation. J. Biol. Chem. 278, 2630-2635(2003)